Just 5% of patients in a cholangiocarcinoma cohort were categorized as microsatellite instability high (MSI-high), but those patients tended to have “excellent” responses to therapy. A new analysis of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results